GPC1 and non-small cell lung carcinoma: In this study, the anti-tumor effect of an anti-GPC1 mAb was evaluated in A549 and H460 NSCLC cell lines and LL97A human lung fibroblasts using a variety of 2D and 3D monoculture and co-culture models and in an orthotopic A549 lung tumor xenograft model.